This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Kutlu Ö, Metin A. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? Dermatol Ther. 2020;33:e13383.KutluÖMetinAA case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?202033e13383Search in Google Scholar
Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083–1084.ShioharaTIijimaMIkezawaZHashimotoKThe diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations200715610831084Search in Google Scholar
Navarro-Bielsa A, Abadías-Granado I, Morales-Callaghan AM, Suso-Estívalez C, Povar-Echeverría M, Rello L, Gilaberte Y. Experience with Cutaneous Manifestations in COVID-19 Patients during the Pandemic. J Clin Med. 2022;11:600.Navarro-BielsaAAbadías-GranadoIMorales-CallaghanAMSuso-EstívalezCPovar-EcheverríaMRelloLGilaberteYExperience with Cutaneous Manifestations in COVID-19 Patients during the Pandemic202211600Search in Google Scholar
Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med. 1995;155:2285–2290.VittorioCCMugliaJJAnticonvulsant hypersensitivity syndrome199515522852290Search in Google Scholar
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071–1080.KardaunSHSekulaPValeyrie-AllanoreLLissYChuCYCreamerDSidoroffANaldiLMockenhauptMRoujeauJCRegiSCAR study groupDrug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study201316910711080Search in Google Scholar
Korem M, Hiller N, Ackerman Z, Chajek-Shaul T, Abramowitz Y. Spleen rupture secondary to anticonvulsant hypersensitivity syndrome. Eur J Intern Med. 2006;17:517–9.KoremMHillerNAckermanZChajek-ShaulTAbramowitzYSpleen rupture secondary to anticonvulsant hypersensitivity syndrome2006175179Search in Google Scholar
Raghavan R, Shawar S. Mechanisms of Drug-Induced Interstitial Nephritis. Adv Chronic Kidney Dis. 2017;24:64–71.RaghavanRShawarSMechanisms of Drug-Induced Interstitial Nephritis2017246471Search in Google Scholar
Um SJ, Lee SK, Kim YH, Kim KH, Son CH, Roh MS, Lee MK. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol. 2010;20:556–562.UmSJLeeSKKimYHKimKHSonCHRohMSLeeMKClinical features of drug-induced hypersensitivity syndrome in 38 patients201020556562Search in Google Scholar
Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module. J Allergy Clin Immunol Pract. 2019;7:633–640.WolfsonARZhouLLiYPhadkeNAChowOABlumenthalKGDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module20197633640Search in Google Scholar
Chaiken BH, Goldberg BI, Segal JP. Dilantin Sensitivity. N Engl J Med. 1950;242:897–898.ChaikenBHGoldbergBISegalJPDilantin Sensitivity1950242897898Search in Google Scholar
Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012;87:435–349.CriadoPRCriadoRFAvanciniJMSantiCGDrug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts201287435349Search in Google Scholar
E L omairi N, Abourazzak S, Chaouki S, Atmani S, Hida M. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review. Pan Afr Med J. 2014;18:19.E L omairiNAbourazzakSChaoukiSAtmaniSHidaMDrug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review20141819Search in Google Scholar
Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH 3rd, Kato T, Lee RE, Yount BL, Mascenik TM, et al. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020;182:429–446.HouYJOkudaKEdwardsCEMartinezDRAsakuraTDinnonKH3rdKatoTLeeREYountBLMascenikTMSARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract2020182429446Search in Google Scholar
Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141–154.HuBGuoHZhouPShiZLCharacteristics of SARS-CoV-2 and COVID-19202119141154Search in Google Scholar
Alfirevic A, Pirmohamed M. Drug induced hypersensitivity and the HLA Complex. Pharmaceuticals. 2010; 23:69–90.AlfirevicAPirmohamedMDrug induced hypersensitivity and the HLA Complex2010236990Search in Google Scholar
Pinto Gouveia M, Gameiro A, Coutinho I, Pereira N, Cardoso JC, Gonçalo M. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. Br J Dermatol. 2016;175:1274–1283.Pinto GouveiaMGameiroACoutinhoIPereiraNCardosoJCGonçaloMOverlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward201617512741283Search in Google Scholar
Bakhtiari S, Sehatpour M, Mortazavi H, Bakhshi M. Orofacial manifestations of adverse drug reactions: a review study. Clujul Med. 2018;91:27–36.BakhtiariSSehatpourMMortazaviHBakhshiMOrofacial manifestations of adverse drug reactions: a review study2018912736Search in Google Scholar
Gowani F, Gehrs B, Scordino T. Drug-induced hypersensitivity syndrome: A clinical, radiologic, and histologic mimic of lymphoma. Case Rep Hematol. 2018;21:7037352.GowaniFGehrsBScordinoTDrug-induced hypersensitivity syndrome: A clinical, radiologic, and histologic mimic of lymphoma2018217037352Search in Google Scholar
Lee SH, Kim MH, Lee K, Jo EJ, Park HK. Hypersensitivity Pneumonitis Caused by Cephalosporins With Identical R1 Side Chains. Allergy Asthma Immunol Res. 2015;7:518–522.LeeSHKimMHLeeKJoEJParkHKHypersensitivity Pneumonitis Caused by Cephalosporins With Identical R1 Side Chains20157518522Search in Google Scholar
Hiransuthikul A, Rattananupong T, Klaewsongkram J, Rerknimitr P, Pongprutthipan M, Ruxrungtham K. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand. Allergol Int. 2016;65:432–438.HiransuthikulARattananupongTKlaewsongkramJRerknimitrPPongprutthipanMRuxrungthamKDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand201665432438Search in Google Scholar
Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006;16:297–306.HungSIChungWHJeeSHChenWCChangYTLeeWRHuSLWuMTChenGSWongTWGenetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions200616297306Search in Google Scholar
McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiūtė D, Carrington M, Sills GJ, Marson T, Jia X, de Bakker PI, et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med. 2011;364:1134–1143.McCormackMAlfirevicABourgeoisSFarrellJJKasperavičiūtėDCarringtonMSillsGJMarsonTJiaXde BakkerPIHLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans201136411341143Search in Google Scholar
Mizukawa Y, Hirahara K, Kano Y, Shiohara T. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J Am Acad Dermatol. 2019;80:670–678.MizukawaYHiraharaKKanoYShioharaTDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease201980670678Search in Google Scholar
Muto Y, Kuse N, Inomata M, Awano N, Tone M, Takada K, Fujimoto K, Bae Y, Kumasaka T, Izumo T. Drug-induced hypersensitivity syndrome caused by minodronic acid hydrate. BMC Pulm Med. 2021;21:350.MutoYKuseNInomataMAwanoNToneMTakadaKFujimotoKBaeYKumasakaTIzumoTDrug-induced hypersensitivity syndrome caused by minodronic acid hydrate202121350Search in Google Scholar
Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021;77:275–289.SharifzadehSMohammadpourAHTavanaeeAElyasiSAntibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review202177275289Search in Google Scholar
Perera V, Gross AS, Polasek TM, Qin Y, Rao G, Forrest A, Xu J, McLachlan AJ. Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia. Expert Opin Drug Metab Toxicol. 2013;9:1115–1137.PereraVGrossASPolasekTMQinYRaoGForrestAXuJMcLachlanAJConsidering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia2013911151137Search in Google Scholar
Lee T, Lee YS, Yoon SY, Kim S, Bae YJ, Kwon HS, Cho YS, Moon HB, Kim TB. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. J Am Acad Dermatol. 2013;69:407–415.LeeTLeeYSYoonSYKimSBaeYJKwonHSChoYSMoonHBKimTBCharacteristics of liver injury in drug-induced systemic hypersensitivity reactions201369407415Search in Google Scholar
Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol. 2006;155:344–349.SeishimaMYamanakaSFujisawaTTohyamaMHashimotoKReactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome2006155344349Search in Google Scholar
Stirton H, Shear NH, Dodiuk-Gad RP. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS. Biomedicines. 2022;10:999.StirtonHShearNHDodiuk-GadRPDrug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS202210999Search in Google Scholar
Sharma A, Saito Y, Hung SI, Naisbitt D, Uetrecht J, Bussiere J. The skin as a metabolic and immune-competent organ: Implications for drug-induced skin rash. J Immunotoxicol. 2019;16:1–12.SharmaASaitoYHungSINaisbittDUetrechtJBussiereJThe skin as a metabolic and immune-competent organ: Implications for drug-induced skin rash201916112Search in Google Scholar
Fleming P, Marik PE. The DRESS syndrome: the great clinical mimicker. Pharmacotherapy. 2011;31:332.FlemingPMarikPEThe DRESS syndrome: the great clinical mimicker201131332Search in Google Scholar
Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609–611.KardaunSHSidoroffAValeyrie-AllanoreLHalevySDavidoviciBBMockenhauptMRoujeauJCVariability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?2007156609611Search in Google Scholar
Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, et al. PREDICT-1 Study Team. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358:568–579.MallalSPhillipsECarosiGMolinaJMWorkmanCTomazicJJägel-GuedesERuginaSKozyrevOCidJFPREDICT-1 Study TeamHLA-B*5701 screening for hypersensitivity to abacavir2008358568579Search in Google Scholar
Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019;68:301–308.ShioharaTMizukawaYDrug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019201968301308Search in Google Scholar
Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59:809–20.PichlerWJTilchJThe lymphocyte transformation test in the diagnosis of drug hypersensitivity20045980920Search in Google Scholar
Hama N, Abe R, Gibson A, Phillips EJ. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis. J Allergy Clin Immunol Pract. 2022;10:1155–1167.HamaNAbeRGibsonAPhillipsEJDrug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis20221011551167Search in Google Scholar
Moling O, Tappeiner L, Piccin A, Pagani E, Rossi P, Rimenti G, Vedovelli C, Mian P. Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir--a hypothesis. Med Sci Monit. 2012;18:57–62.MolingOTappeinerLPiccinAPaganiERossiPRimentiGVedovelliCMianPTreatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir--a hypothesis2012185762Search in Google Scholar
Dolja VV, Koonin EV. Metagenomics reshapes the concepts of RNA virus evolution by revealing extensive horizontal virus transfer. Virus Res. 2018;244:36–52.DoljaVVKooninEVMetagenomics reshapes the concepts of RNA virus evolution by revealing extensive horizontal virus transfer20182443652Search in Google Scholar
Eurosurveillance editorial team. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveill. 2020;25:200131.Eurosurveillance editorial teamNote from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern202025200131Search in Google Scholar
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271–280.HoffmannMKleine-WeberHSchroederSKrügerNHerrlerTErichsenSSchiergensTSHerrlerGWuNHNitscheASARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor2020181271280Search in Google Scholar
Zhao W, Li H, Li J, Xu B, Xu J. The mechanism of multiple organ dysfunction syndrome in patients with COVID-19. J Med Virol. 2022;94:1886–1892.ZhaoWLiHLiJXuBXuJThe mechanism of multiple organ dysfunction syndrome in patients with COVID-1920229418861892Search in Google Scholar
Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, et al. HCA Lung Biological Network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681–687.SungnakWHuangNBécavinCBergMQueenRLitvinukovaMTalavera-LópezCMaatzHReichartDSampaziotisFHCA Lung Biological Network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes202026681687Search in Google Scholar
Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, Scherschel K, Kirchhof P, Escher F, Schultheiss HP, et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020;5:1281–1285.LindnerDFitzekABräuningerHAleshchevaGEdlerCMeissnerKScherschelKKirchhofPEscherFSchultheissHPAssociation of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases2020512811285Search in Google Scholar
Wang J, Zheng Y, Chen Y, Hu X, Peng M, Fang Y, Shen B, Lu G. Laboratory indicators in COVID-19 and other pneumonias: Analysis for differential diagnosis and comparison of dynamic changes during 400-day follow-up. Comput Struct Biotechnol J. 2021;19:2497–2507.WangJZhengYChenYHuXPengMFangYShenBLuGLaboratory indicators in COVID-19 and other pneumonias: Analysis for differential diagnosis and comparison of dynamic changes during 400-day follow-up20211924972507Search in Google Scholar
Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14:185–192.ZouXChenKZouJHanPHaoJHanZSingle-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection202014185192Search in Google Scholar
Chen J, Lau YF, Lamirande EW, Paddock CD, Bartlett JH, Zaki SR, Subbarao K. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol. 2010;84:1289–1301.ChenJLauYFLamirandeEWPaddockCDBartlettJHZakiSRSubbaraoKCellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection20108412891301Search in Google Scholar
Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, Mencarini J, Caporale R, Peruzzi B, Antonelli A, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130:4694–4703.MazzoniASalvatiLMaggiLCaponeMVanniASpinicciMMencariniJCaporaleRPeruzziBAntonelliAImpaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent202013046944703Search in Google Scholar
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–1720.GuanWJNiZYHuYLiangWHOuCQHeJXLiuLShanHLeiCLHuiDSCChina Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China202038217081720Search in Google Scholar
Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39:517–528.ChoustermanBGSwirskiFKWeberGFCytokine storm and sepsis disease pathogenesis201739517528Search in Google Scholar
Ito A, Ishida T, Nakanishi Y, Kobe H, Tokioka F. Eosinopenia is associated with adverse outcomes after COVID-19 infection: A perspective from Japan. Respirology. 2023;28:677–680.ItoAIshidaTNakanishiYKobeHTokiokaFEosinopenia is associated with adverse outcomes after COVID-19 infection: A perspective from Japan202328677680Search in Google Scholar
Xie G, Ding F, Han L, Yin D, Lu H, Zhang M. The role of peripheral blood eosinophil counts in COVID-19 patients. Allergy. 2021;76:471–482.XieGDingFHanLYinDLuHZhangMThe role of peripheral blood eosinophil counts in COVID-19 patients202176471482Search in Google Scholar
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–2629.ChenGWuDGuoWCaoYHuangDWangHWangTZhangXChenHYuHClinical and immunological features of severe and moderate coronavirus disease 2019202013026202629Search in Google Scholar
Birhanu A, Ayana GM, Merga BT, Alemu A, Negash B, Seid A, Dessie Y. Incidence and predictors of organ failure among COVID-19 hospitalized adult patients in Eastern Ethiopia. Hospital-based retrospective cohort study. BMC Infect Dis. 2022;22:412.BirhanuAAyanaGMMergaBTAlemuANegashBSeidADessieYIncidence and predictors of organ failure among COVID-19 hospitalized adult patients in Eastern Ethiopia. Hospital-based retrospective cohort study202222412Search in Google Scholar
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, Mou HM, Wang LH, Zhang HR, Fu WJ, et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49:411–417.YaoXHLiTYHeZCPingYFLiuHWYuSCMouHMWangLHZhangHRFuWJA pathological report of three COVID-19 cases by minimal invasive autopsies202049411417Search in Google Scholar
Jamshidi P, Hajikhani B, Mirsaeidi M, Vahidnezhad H, Dadashi M, Nasiri MJ. Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review. Front Med (Lausanne). 2021;8:634208.JamshidiPHajikhaniBMirsaeidiMVahidnezhadHDadashiMNasiriMJSkin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review20218634208Search in Google Scholar
Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395:689–697.WuJTLeungKLeungGMNowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study2020395689697Search in Google Scholar
Sueki H, Sasaki M, Kamiyama T, Ohtoshi S, Watanabe H, Nakada T. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with histologic features mimicking cutaneous pseudolymphoma. J Dermatol. 2014;41:856–857.SuekiHSasakiMKamiyamaTOhtoshiSWatanabeHNakadaTDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with histologic features mimicking cutaneous pseudolymphoma201441856857Search in Google Scholar
Herman A, Matthews M, Mairlot M, Nobile L, Fameree L, Jacquet LM, Baeck M. Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19. J Eur Acad Dermatol Venereol. 2020;34:768–700.HermanAMatthewsMMairlotMNobileLFamereeLJacquetLMBaeckMDrug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19202034768700Search in Google Scholar
Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007;157:934–40.TohyamaMHashimotoKYasukawaMKimuraHHorikawaTNakajimaKUranoYMatsumotoKIijimaMShearNHAssociation of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome200715793440Search in Google Scholar
Kano Y, Hiraharas K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol. 2006;155:301–306.KanoYHiraharasKSakumaKShioharaTSeveral herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease2006155301306Search in Google Scholar
Thomas K, Saadabadi A. Olanzapine. PubMed. Treasure Island (FL): StatPearls Publishing; 2022.ThomasKSaadabadiATreasure Island (FL)StatPearls Publishing2022Search in Google Scholar
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454.LiWMooreMJVasilievaNSuiJWongSKBerneMASomasundaranMSullivanJLLuzuriagaKGreenoughTCAngiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus2003426450454Search in Google Scholar
Czerwensky F, Leucht S, Steimer W. CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations. Ther Drug Monit. 2015;37:152–160.CzerwenskyFLeuchtSSteimerWCYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations201537152160Search in Google Scholar
Cruz VB, Júnior LFFF, Kobal CR, da Silva NA. Does sensitization by SARS-CoV-2 immune complexes trigger DRESS syndrome? Braz J Infect Dis. 2022;26:102337.CruzVBJúniorLFFFKobalCRda SilvaNADoes sensitization by SARS-CoV-2 immune complexes trigger DRESS syndrome?202226102337Search in Google Scholar
Ramirez GA, Della-Torre E, Tresoldi M, Scarpellini P, Ciceri F, Dagna L, Yacoub MR. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clin Microbiol Infect. 2021;27:1190–1192.RamirezGADella-TorreETresoldiMScarpelliniPCiceriFDagnaLYacoubMRDrug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-1920212711901192Search in Google Scholar